The Influence of Hormonal Replacement Therapy on Lipid and Lipoprotein Metabolism

References

• Boman G, Böttiger L E., Westerholm B. Biverkningar vid användning av p-piller. En jämförelse mellan 1966–70 och 1974–78. Läkartidn 1980; 77: 2249
   Google Scholar
• Bradley D D., Wingerd J, Petitti D B., Krauss R M., Ramcharan S. Serum high-density lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 1978; 299: 17
   PubMed Web of Science ®Google Scholar
• Carlsson L A., Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis 1975; 21: 417
   PubMed Web of Science ®Google Scholar
• Castelli W P., Doyle J T., Gordon T, Haines C G., Hjortland M C., Hulley S B., Kagan A, Zukel W J. HDL cholesterol and other lipids in coronary heart disease. Circulation 1977; 55(5)767
   PubMed Web of Science ®Google Scholar
• Crona N, Silfverstolpe G, Samsioe G. Does progestogen reduction in oral contraception parallel reduced lipid metabolic effects?. Acta Obstet Gynecol Scand 1982, suppl. 105: 41
   Google Scholar
• Crona N. Hormonal treatment and lipoprotein metabolism. Effects of exogenous sex steroids used for contraception, hormonal replacement and adjuvant cancer therapy. Dissertation, University of Gothenburg. 1983
   Google Scholar
• Crona N, Enk L, Lindberg U B., Samsioe G, Silverstolpe G. Effects on serum lipoproteins of 2 and 4 mg estradiol valerate (E2V). Proceedings of the XXIV Nordic Congress on Obstetrics and Gynecology. Odense 1984
   Google Scholar
• Dyerberg J, HjOrne N. Plasma lipid and lipoprotein levels in childhood and adolescence. Scand J Clin Lab Invest 1973; 31: 473
   PubMed Web of Science ®Google Scholar
• Goldbourt U, Medalie J H. High density lipoprotein cholesterol and incidence of coronary heart disease. The Israeli ischemic heart disease study. Am J Epidemiol 1979; 109: 296
   PubMed Web of Science ®Google Scholar
• Goldzieher J W., Chenault C B., de la Pena A, Dozier T S., Kremer D C. Comparative studies of the ethinyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons and beagles. Fertil Steril 1978; 30: 522
   PubMed Web of Science ®Google Scholar
• Heiss G, Tamir J, Davis C E. Lipoprotein-cholesterol distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study. Circulation 1980; 61: 302
   PubMed Web of Science ®Google Scholar
• Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560
   PubMed Web of Science ®Google Scholar
• Huttunen J K., Ehnholm C, Kekki M, Nikkilä E A. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyce-ridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med 1976; 50: 249
   PubMedGoogle Scholar
• Inman W HW, Vessey M P., Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J 1970; ii: 203
   Google Scholar
• Larsson-Cohn U, Fåhreus L, Wallentin L, Zador G. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril 1981; 35: 115
   Google Scholar
• Lewis B, Chait A, Oakley C MO, Wooton I DP, Krikler D M., Onitiri A, Sigurdsson G, February A. Serum lipoprotein abnormalities in patients with ischemic heart disease: comparison with a control population. Br Med J 1974; iii: 489
   Google Scholar
• Lipid Research Clinics Program. The lipid research clinics' coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365
   PubMed Web of Science ®Google Scholar
• Mattsson L, Cullberg G, Samsioe G. Influence of esterified estrogens and medroxyprogesterone on lipid metabolism and sex steroids. A study in oophorectomized women. Horm Metabol Res 1982; 14: 602
   Google Scholar
• Mattsson L Å. Gonadal hormones and lipid metabolism in women—effects of endogenous and exogenous sex steroids. Dissertation, University of Gothenburg. 1984
   Google Scholar
• McGill H C., Jr, Stern M P. Sex and atherosclerosis. Atheroscl Rev, R Paoletti, A M. Gotto, Jr. Raven Press, New York 1979; 157
   Google Scholar
• Meade T W., Greenberg G, Thompson S G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50-and 30 μg oestrogen preparations. Br Med J 1980; 280: 1157
   PubMed Web of Science ®Google Scholar
• Miller G J., Miller N E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; i: 16
   Google Scholar
• Miller N E., Hammett F, Saltissi S, Rao S, van Zeller H, Coltart J, Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein sub-fractions and apolipoproteins. Br Med J 1981; 282: 1741
   PubMed Web of Science ®Google Scholar
• Notelovitz M, Gudat J C., Ware M D., Dougherty M C. Oestrogen—progestin therapy and the lipid balance of postmenopausal women. Maturitas 1982; 4: 301
   Google Scholar
• Rhoads G G., Gulbrandsen C L., Kagan A. Serum lipoprotein and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med 1976; 294: 293
   PubMed Web of Science ®Google Scholar
• Ross R K., Paganini-Hill A, Mack T M., Arthur M, Henderson B E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981; i: 858
   Google Scholar
• Sammel N, Simons L A., Hickie J B., Gibson J C. Coronary artery disease in young Australian women. Med J Aust 1978; 2: 495
   Google Scholar
• Silfverstolpe G, Gustafson A, Samsioe G, Svanborg A. Lipid metabolic studies in oophorectomized women. Effects of three different progestogens. Acta Obstet Gynecol Scand 1979, suppl. 88: 89
   Google Scholar
• Silfverstolpe G, Gustafson A, Samsioe G, Svanborg A. Lipid metabolic studies in oophorectomized women. Effects induced by two different estrogens on serum lipids and lipoproteins. Gynecol Obstet Invest 1980; 11: 161
   PubMedGoogle Scholar
• Silfverstolpe G, Johnson P, Samsioe G, Svanborg A, Gustafson A. Effects induced by the addition of nor-ethisterone acetate to two different estrogens on serum individual phospholipids and serum lecithin fatty acid composition. Acta Endocrinol 1981; 96: 527
   Google Scholar
• Wallentin L, Larsson-Cohn U. Metabolic and hormonal effects of postmenopausal oestrogen replacement. II. Plasma lipids. Acta Endocrinol 1977; 86: 597
   PubMedGoogle Scholar